Twice-daily versus thrice-daily clarithromycin in combination with ranitidine bismuth citrate in the eradication of Helicobacter pylori. [electronic resource]
Producer: 19990805Description: 121-7 p. digitalISSN:- 1083-4389
- Adult
- Anti-Bacterial Agents -- therapeutic use
- Anti-Ulcer Agents -- therapeutic use
- Bismuth -- adverse effects
- Clarithromycin -- adverse effects
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Helicobacter Infections -- drug therapy
- Helicobacter pylori -- drug effects
- Humans
- Male
- Microbial Sensitivity Tests
- Middle Aged
- Ranitidine -- adverse effects
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.